The Effects of Circadian Gene on Sleep and Associated Symptoms in Breast Cancer Patients Under Chemotherapy

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Breast Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT01887925
BreastCaCTx_circadian

Details and patient eligibility

About

The purpose of this study is the evaluation of effect of circadian gene on sleep and other symptoms in breast cancer patients under chemotherapy.

Full description

In this study, the investigators are going to examine the effect of genetic polymorphism on sleep, anxiety, depression and other cancer-related symptoms in patients with breast cancer who have started chemotherapy after surgery. No intervention was intended and blood sample was taken with other routine laboratory tests.

Enrollment

224 patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 18-70
  • Patient with breast cancer without metastasis
  • Patient received cancer surgery and medically stable
  • Patient will undergo chemotherapy for the first time in life
  • Patient have signed on the informed consent, and well understood the objective and procedure of this study

Exclusion criteria

  • Patient received chemotherapy or radiotherapy
  • Patient had another cancer before
  • Patient have metastasis
  • Patient with severe medical condition
  • Patient had taken psychiatric medication more than 1 month in life
  • Patient worked the night shift for more than 1 month in 6 months

Trial design

224 participants in 1 patient group

breast cancer
Description:
breast cancer patients receiving chemotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems